Imaging study for hand arthritis using a new tracer
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests a new imaging substance (called 99mTc-NTP 15-5) for people with hand arthritis (either rheumatoid arthritis or osteoarthritis). It aims to see if the substance can help doctors see joint inflammation and damage better, which could improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally in good health (score above 70 on daily activity scale).
- You have a firm diagnosis of rheumatoid arthritis or osteoarthritis in your fingers, with pain greater than 4 out of 10.
- If you have osteoarthritis, you must stop taking non-steroidal anti-inflammatory drugs (NSAIDs like ibuprofen) at least 8 days before the injection.
- You have not had any surgery on your hands or joint injections in the last month.
- You are not pregnant or breastfeeding.
- You have a body mass index (BMI) of 30 or less.
- You are not currently taking certain biologic drugs for rheumatoid arthritis (like anti-TNF, rituximab, abatacept, anti-IL6, or JAK inhibitors).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how heart-and-blood-vessel risk differs in people with digital osteoarthritis (arthritis affecting the fingers). It may help doctors understand whether finger osteoarthritis is linked with higher cardiovascular risk.
This trial tests a new imaging scan (SPECT) that uses a special tracer (99mTc-TCR-FAPI) to see inflammation in the joints of people with rheumatoid arthritis. It aims to help doctors better understand and track disease activity.
This trial uses a special PET scan to see how an experimental drug, CIT-013, targets inflammation in the body. It's for people with rheumatoid arthritis to better understand how the drug works.
This study tests whether a special scan can help doctors decide if you can safely reduce your rheumatoid arthritis medication. It may help you taper your treatment while keeping your disease under control.
This trial is testing a new way to catch rheumatoid arthritis early using a smartphone tool that records how your hands look and move. If you have early hand pain and a positive ACPA blood test, this study might help detect the disease sooner and guide earlier care.
This study follows people with early finger (hand) osteoarthritis symptoms to better understand how the condition starts and changes. You may be asked for blood tests, symptom checks, and imaging to see what’s happening in the joints.
Hear when a new Digital Osteoarthritis or Rheumatoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.